Physician profile
Walter Ohara
NPI 1376541789
$9,676.21
in general payments reported to CMS, 2019-2025
32 companies · $1,490 in 2025
The $1,490 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,081 · 2020: $509 · 2021: $518 · 2022: $1,739 · 2023: $3,141 · 2024: $1,198 · 2025: $1,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,792 · Travel and Lodging: $2,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,792.22 |
| Travel and Lodging | $2,036.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,745.69 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $1,434.20 | 2019-2025 | Mitraclip, Triclip, Navitor |
| Atricure, INC. | $1,271.54 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Abiomed | $1,195.00 | 2022-2025 | Impella |
| Intuitive Surgical, INC. | $891.66 | 2023 | Da Vinci Surgical System |
| Edwards Lifesciences Corporation | $470.56 | 2022-2024 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $438.92 | 2024-2025 | Lifevest |
| Pfizer INC. | $250.63 | 2019-2021 | |
| Angiodynamics, INC. | $248.80 | 2022 | |
| Baxter Healthcare | $244.10 | 2019-2021 | |
| Depuy Synthes Sales INC. | $196.18 | 2022-2025 | Matrixrib, Na |
| Livanova USA, INC. | $190.68 | 2019-2020 | |
| Boston Scientific Corporation | $166.53 | 2019 | |
| Medtronic Vascular, INC. | $134.16 | 2019-2020 | |
| Inari Medical, INC. | $123.31 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $93.12 | 2019 | |
| Bolton Medical INC | $55.77 | 2025 | Treo Abdominal Stent-Graft System |
| Bard Peripheral Vascular, INC. | $51.93 | 2019 | |
| Kci USA, INC. | $51.06 | 2019-2022 | |
| Davol INC. | $49.12 | 2022 | |
| Clearflow INC. | $49.06 | 2022 | |
| Silk Road Medical, INC. | $44.74 | 2020-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Janssen Pharmaceuticals, INC | $42.57 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $37.52 | 2021-2022 | |
| Normatec Industries, LP | $32.42 | 2019-2020 | |
| Bard Access Systems, INC. | $31.22 | 2019 | |
| Penumbra, INC. | $28.01 | 2024 | Indigo System |
| Shockwave Medical, INC | $23.89 | 2022 | |
| Amarin Pharma, INC. | $23.03 | 2021 | |
| Hartmann USA, INC. | $21.74 | 2023 | Zetuvit Plus |
| Biom'Up Sa | $21.06 | 2019 | |
| Amgen INC. | $17.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Ohara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.